Author:
Wallrauch C.,Elsner E.,Milatovic D.,Cremer J.,Braveny I.
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Arthur, M., P. Courvalin: Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37 (1993), 1563–1571.
2. Bonten, J. M., C. A. Gaillard, F. H. van Thiel, S. van der Geest, E. E. Stobberingh: Colonization and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob. Agents Chemother. 39 (1995), 2783–2786.
3. Centers for Disease Control and Prevention: Nosocomial enterococci resistant to vancomycin: United States, 1989–1993 National Nosocomial Infection Surveillance. MMWR 42 (1993), 597–599.
4. Centers for Disease Control and Prevention: Recommendations for preventing the spread of vancomycin resistance. MMWR 44 RR 12 (1995), 1–13.
5. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, F. C. Tenover: Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37 (1993), 2311–2317.